Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building,
CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,
UC = Conference Chicago at University Center
* = applied session ! = JSM meeting theme
133 * !
Mon, 8/1/2016,
8:30 AM -
10:20 AM
CC-W185a
Adaptive Designs in Clinical Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Jose Pinheiro, Johnson & Johnson
8:35 AM
Conditional Power for Testing Equivalence of Two Proportions
—
Zejiang Yang, INC Research ; Kalyan Ghosh, INC Research
8:50 AM
Bayesian Response-Adaptive Covariate-Adjusted Randomization Design for Clinical Trials
—
Jianchang Lin, Takeda ; LiAn Lin, Merck Research Laboratories ; Serap Sankoh, Takeda ; Fang Yang, Vertex Pharmaceuticals ; Guohui Liu, Takeda
9:05 AM
Consideration of the T-Statistic Adaptive Dose-Finding Design for Estimating Maximum Tolerated Dose
—
James Bolognese, Cytel
9:20 AM
On Exact Sample Size of K-Stage Group Sequential Designs for Rare Diseases
—
Man Jin
9:35 AM
Bayesian Adaptive Design for Trials with Delayed Binary Outcome Using Historical Control Data
—
Nusrat Harun, Cincinnati Children's Hospital ; Mi-Ok Kim, Cincinnati Children's Hospital Medical Center ; Chunyan Liu, Cincinnati Children's Hospital
9:50 AM
Evaluation of Adaptive Sequential Designs in the Setting of Anticipated Crossing Survival
—
William Koh, University of Washington ; Scott Emerson, University of Washington
10:05 AM
Risk Analysis on Using Surrogate Endpoint at Interim Analysis
—
Ziqian Geng, AbbVie ; Bo Fu, AbbVie ; Alan Hartford, AbbVie ; Jun Zhao, AbbVie
